Literature DB >> 15687255

A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73.

Gad Asher1, Peter Tsvetkov, Chaim Kahana, Yosef Shaul.   

Abstract

Protein degradation is an essential and highly regulated process. The proteasomal degradation of the tumor suppressors p53 and p73 is regulated by both polyubiquitination and by an ubiquitin-independent process. Here, we show that this ubiquitin-independent process is mediated by the 20S proteasomes and is regulated by NQO1. NQO1 physically interacts with p53 and p73 in an NADH-dependent manner and protects them from 20S proteasomal degradation. Remarkably, the vast majority of NQO1 in cells is found in physical association with the 20S proteasomes, suggesting that NQO1 functions as a gatekeeper of the 20S proteasomes. We further show that this pathway plays a role in p53 accumulation in response to ionizing radiation. Our findings provide the first evidence for in vivo degradation of p53 and p73 by the 20S proteasomes and its regulation by NQO1 and NADH level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15687255      PMCID: PMC546509          DOI: 10.1101/gad.319905

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  23 in total

Review 1.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 2.  Proteasomes and their kin: proteases in the machine age.

Authors:  Cecile M Pickart; Robert E Cohen
Journal:  Nat Rev Mol Cell Biol       Date:  2004-03       Impact factor: 94.444

Review 3.  Structure and functions of the 20S and 26S proteasomes.

Authors:  O Coux; K Tanaka; A L Goldberg
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 4.  Lessons from the discovery of the ubiquitin system.

Authors:  A Hershko
Journal:  Trends Biochem Sci       Date:  1996-11       Impact factor: 13.807

5.  Properties and reaction mechanism of DT diaphorase from rat liver.

Authors:  S Hosoda; W Nakamura; K Hayashi
Journal:  J Biol Chem       Date:  1974-10-25       Impact factor: 5.157

6.  Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.

Authors:  D R Chowdary; J J Dermody; K K Jha; H L Ozer
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

7.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

9.  Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis.

Authors:  Q Ma; K Cui; F Xiao; A Y Lu; C S Yang
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

10.  A unified pathway for the degradation of ornithine decarboxylase in reticulocyte lysate requires interaction with the polyamine-induced protein, ornithine decarboxylase antizyme.

Authors:  E Mamroud-Kidron; M Omer-Itsicovich; Z Bercovich; K E Tobias; E Rom; C Kahana
Journal:  Eur J Biochem       Date:  1994-12-01
View more
  158 in total

1.  Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.

Authors:  Olga A Guryanova; Judith A Drazba; Elena I Frolova; Peter M Chumakov
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

3.  Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.

Authors:  Valerie Edmond; Elodie Moysan; Saadi Khochbin; Patrick Matthias; Christian Brambilla; Elisabeth Brambilla; Sylvie Gazzeri; Beatrice Eymin
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

Review 4.  Ubiquitin and ubiquitin-like modifications of the p53 family.

Authors:  Ian R Watson; Meredith S Irwin
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

5.  Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Authors:  Jihane Basbous; Dany Chalbos; Robert Hipskind; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

6.  Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues.

Authors:  Aldrin V Gomes; Glen W Young; Yueju Wang; Chenggong Zong; Mansoureh Eghbali; Oliver Drews; Haojie Lu; Enrico Stefani; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2008-10-17       Impact factor: 5.911

7.  c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics.

Authors:  Julia Adler; Nina Reuven; Chaim Kahana; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

8.  Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.

Authors:  B A Patrick; X Gong; A K Jaiswal
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

9.  Site-specific methionine oxidation initiates calmodulin degradation by the 20S proteasome.

Authors:  Edward M Balog; Elizabeth L Lockamy; David D Thomas; Deborah A Ferrington
Journal:  Biochemistry       Date:  2009-04-07       Impact factor: 3.162

10.  NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b).

Authors:  Marco Garate; Ronald P C Wong; Eric I Campos; Yemin Wang; Gang Li
Journal:  EMBO Rep       Date:  2008-04-04       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.